Recent GRI News
- GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase • GlobeNewswire Inc. • 05/18/2026 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 12:36:07 PM
- GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline • GlobeNewswire Inc. • 05/14/2026 12:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:16:38 PM
- GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment • GlobeNewswire Inc. • 02/17/2026 02:15:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 07:10:51 PM
- GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial • GlobeNewswire Inc. • 02/05/2026 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/04/2026 01:48:49 PM
- GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights • GlobeNewswire Inc. • 02/04/2026 01:45:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 01/30/2026 12:34:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2026 01:46:11 PM
- GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF • GlobeNewswire Inc. • 01/28/2026 01:45:00 PM
- GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures • GlobeNewswire Inc. • 01/26/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2026 09:10:37 PM
- GRI Bio Announces Reverse Stock Split • GlobeNewswire Inc. • 01/21/2026 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 01:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 03:15:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 01:31:40 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/09/2026 01:31:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:01:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/29/2025 01:08:04 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/19/2025 01:48:54 PM
